Back HCV Policy & Advocacy

HCV Policy & Advocacy

Advocates Urge Consideration of Hepatitis C Treatment for Active Injection Drug Users

Advocates with the Treatment Action group (TAG) have successfully urged hepatology experts to change hepatitis C management guidelines to eliminate a recommendation that substance users should be abstinent from drugs or alcohol for 6 months before they are eligible for treatment.

Read more: